PACAP (6-27) (human, ovine, rat)
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP) . PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases[1].
Product Specifications
CAS Number
136134-68-4
Product Name Alternative
Pituitary adenylate cyclase-activating peptide (6-27)
UNSPSC
12352209
Target
Adenylate Cyclase
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pacap-6-27-human-ovine-rat.html
Purity
98.89
Solubility
DMSO : ≥ 100 mg/mL
Smiles
[Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2]
Molecular Formula
C121H193N33O31S
Molecular Weight
2638.09
References & Citations
[1]Gaspo R, et al. Canine adrenal catecholamine response to VIP is blocked by PACAP- (6-27) in vivo. Am J Physiol. 1997 May;272 (5 Pt 2) :R1606-12.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Pmel17 / gp100 / SILV (NKI-beteb), CF640R conjugate, 0.1mg/mL
Fibronectin (Fn-3), CF647 conjugate, 0.1mg/mL
Von Willebrand Factor (3E2D10), CF405S conjugate, 0.1mg/mL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
